Vitamin D-dependent suppression of human atrial natriuretic peptide gene promoter activity requires heterodimer assembly

被引:18
作者
Chen, SC
Costa, CHRM
Nakamura, K
Ribeiro, RCJ
Gardner, DG [1 ]
机构
[1] Univ Calif San Francisco, Metab Res Unit, San Francisco, CA 94143 USA
[2] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA
[3] Univ Brasilia, Dept Pharmaceut Sci, BR-70910900 Brasilia, DF, Brazil
关键词
D O I
10.1074/jbc.274.16.11260
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Crystallographic structures of the ligand-binding domains for the retinoid X (RXR) and estrogen receptors have identified conserved surface residues that participate in dimer formation. Homologous regions have been identified in the human vitamin D receptor (hVDR). Mutating Lys-386 to Ala (K386A) in hVDR significantly reduced binding to glutathione S-transferase-RXR alpha in solution3 whereas binding of an I384R/Q385R VDR mutant was almost undetectable. The K386A mutant formed heterodimers with RXR alpha on DR-3 (a direct repeat of AG-GTCA spaced by three nucleotides), whereas the I384R/Q385R mutant completely eliminated heterodimer formation. Wild type hVDR effected a 3-fold induction of DR-3-dependent thymidine kinase-luciferase activity in cultured neonatal rat atrial myocytes, an effect that was increased to 8-9-fold by cotransfected hRXR alpha. Induction by K386A, in the presence or absence of RXRa, was only slightly lower than that seen with wild type VDR. On the other hand, I384R/Q385R alone displayed no stimulatory activity and less than 2-fold induction in the presence of hRXR alpha. Qualitatively similar findings were observed with the negative regulation of the human atrial natriuretic peptide gene promoter by these mutants. Collectively, these studies identify specific amino acids in hVDR that play a critical role in heterodimer formation and subsequent modulation of gene transcription.
引用
收藏
页码:11260 / 11266
页数:7
相关论文
共 39 条
[1]   CLONING AND EXPRESSION OF FULL-LENGTH CDNA-ENCODING HUMAN VITAMIN-D RECEPTOR [J].
BAKER, AR ;
MCDONNELL, DP ;
HUGHES, M ;
CRISP, TM ;
MANGELSDORF, DJ ;
HAUSSLER, MR ;
PIKE, JW ;
SHINE, J ;
OMALLEY, BW .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1988, 85 (10) :3294-3298
[2]  
BAUER RF, 1976, IN VITRO CELL DEV B, V12, P558
[3]   CRYSTAL-STRUCTURE OF THE LIGAND-BINDING DOMAIN OF THE HUMAN NUCLEAR RECEPTOR RXR-ALPHA [J].
BOURGUET, W ;
RUFF, M ;
CHAMBON, P ;
GRONEMEYER, H ;
MORAS, D .
NATURE, 1995, 375 (6530) :377-382
[4]   Molecular basis of agonism and antagonism in the oestrogen receptor [J].
Brzozowski, AM ;
Pike, ACW ;
Dauter, Z ;
Hubbard, RE ;
Bonn, T ;
Engstrom, O ;
Ohman, L ;
Greene, GL ;
Gustafsson, JA ;
Carlquist, M .
NATURE, 1997, 389 (6652) :753-758
[5]  
CAO X, 1993, J BIOL CHEM, V268, P27371
[6]   2 NUCLEAR SIGNALING PATHWAYS FOR VITAMIN-D [J].
CARLBERG, C ;
BENDIK, I ;
WYSS, A ;
MEIER, E ;
STURZENBECKER, LJ ;
GRIPPO, JF ;
HUNZIKER, W .
NATURE, 1993, 361 (6413) :657-660
[7]   Suppression of ANP gene transcription by liganded vitamin D receptor - Involvement of specific receptor domains [J].
Chen, SC ;
Wu, JM ;
Hsieh, JC ;
Whitfield, GK ;
Jurutka, PW ;
Haussler, MR ;
Gardner, DG .
HYPERTENSION, 1998, 31 (06) :1338-1342
[8]   LIGAND MODULATES THE CONVERSION OF DNA-BOUND VITAMIN D-3 RECEPTOR (VDR) HOMODIMERS INTO VDR-RETINOID-X RECEPTOR HETERODIMERS [J].
CHESKIS, B ;
FREEDMAN, LP .
MOLECULAR AND CELLULAR BIOLOGY, 1994, 14 (05) :3329-3338
[9]   SEQUENCES IN THE HUMAN PARATHYROID-HORMONE GENE THAT BIND THE 1,25-DIHYDROXYVITAMIN-D3 RECEPTOR AND MEDIATE TRANSCRIPTIONAL REPRESSION IN RESPONSE TO 1,25-DIHYDROXYVITAMIN-D3 [J].
DEMAY, MB ;
KIERNAN, MS ;
DELUCA, HF ;
KRONENBERG, HM .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1992, 89 (17) :8097-8101
[10]   Nuclear receptor-binding sites of coactivators glucocorticoid receptor interacting protein 1 (GRIP1) and steroid receptor coactivator 1 (SRC-1): Multiple motifs with different binding specificities [J].
Ding, XF ;
Anderson, CM ;
Ma, H ;
Hong, H ;
Uht, RM ;
Kushner, PJ ;
Stallcup, MR .
MOLECULAR ENDOCRINOLOGY, 1998, 12 (02) :302-313